Potential role of odanacatib in the treatment of osteoporosis

QR Code

Potential role of odanacatib in the treatment of osteoporosis

Kong Wah NgDepartment of Endocrinology and Diabetes and St Vincent’s Institute, St Vincent’s Hospital, Fitzroy, Victoria, AustraliaAbstract: Cathepsin K is a key enzyme involved in the degradation of organic bone matrix by osteoclasts. Inhibition of bone resorption observed in hu...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Ng KW
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2012
Sujets:	selective cathepsin K inhibitors odanacatib bone remodeling osteoclast bone turnover markers Geriatrics RC952-954.6
Accès en ligne:	https://doaj.org/article/7f6e9d6c6dfc43fabb793dabdc9fe2be
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
par: Mederle OA, et autres
Publié: (2018)

Relationship between abnormal glucose metabolism and osteoporosis in Han Chinese men over the age of 50 years
par: Liu M, et autres
Publié: (2019)

Analysis of three-dimensional bone mineral density and bone strength measured by quantitative computed tomography following denosumab discontinuation in a patient with postmenopausal osteoporosis
par: Tsuchiya K, et autres
Publié: (2019)

Association between biomarkers of bone health and osteosarcopenia among Iranian older people: The Bushehr Elderly Health (BEH) program
par: Maryam Fathi, et autres
Publié: (2021)

Effects of annatto-derived tocotrienol supplementation on osteoporosis induced by testosterone deficiency in rats
par: Chin KY, et autres
Publié: (2014)

Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis
par: Liu Z, et autres
Publié: (2020)

Plasma homocysteine level is a risk factor for osteoporotic fractures in elderly patients
par: Zhu Y, et autres
Publié: (2016)

Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature
par: Jun Iwamoto, et autres
Publié: (2008)

High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis
par: Ishikawa K, et autres
Publié: (2018)

Early changes in 25-hydroxyvitamin D levelsand bone markers after monthly risedronatewith cholecalciferol in Korean patients with osteoporosis
par: Chung HY, et autres
Publié: (2013)

The Associations of Serum Vitamin D and Bone Turnover Markers with the Type and Severity of Hip Fractures in Older Women
par: Zhao J, et autres
Publié: (2020)

Some aspects of bone remodeling around dental implants
par: da Silva Mello,Amaro Sérgio, et autres
Publié: (2018)

Emerging treatments for postmenopausal osteoporosis – focus on denosumab
par: Piet Geusens
Publié: (2009)

Eldecalcitol for the treatment of osteoporosis
par: Noguchi Y, et autres
Publié: (2013)

LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
par: Yu H, et autres
Publié: (2019)

Modulation of in vitro Osteoclast Activity Mediated by Different Doses of Parathyroid Hormone
par: Ginani,Fernanda, et autres
Publié: (2017)

Educational program for orthopedic surgeons’ influences for osteoporosis
par: Zhuang Huafeng, et autres
Publié: (2021)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
par: Fujiwara S, et autres
Publié: (2014)

Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report
par: Nishikawa A, et autres
Publié: (2016)

Management of bone metastases in refractory prostate cancer – role of denosumab
par: Paller CJ, et autres
Publié: (2012)

Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
par: Luigi Gennari, et autres
Publié: (2010)

BFH-OSTM, a new predictive screening tool for identifying osteoporosis in elderly Han Chinese males
par: Lin J, et autres
Publié: (2017)

Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer
par: Stefano Gonnelli, et autres
Publié: (2008)

Pharmacological Therapy of Osteoporosis: What’s New?
par: Iolascon G, et autres
Publié: (2020)

Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study
par: Lu C, et autres
Publié: (2017)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
par: María J Moro-Álvarez, et autres
Publié: (2008)

Lactobacillus helveticus (ATCC 27558) upregulates Runx2 and Bmp2 and modulates bone mineral density in ovariectomy-induced bone loss rats
par: Parvaneh M, et autres
Publié: (2018)

Teriparatide in the management of osteoporosis
par: Donald Bodenner, et autres
Publié: (2008)

Flavonoids: Classification, Function, and Molecular Mechanisms Involved in Bone Remodelling
par: Priyanka Ramesh, et autres
Publié: (2021)

Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
par: Filip R, et autres
Publié: (2018)

Factors associated with decreased bone mineral density in postmenopausal women with schizophrenia
par: Liang Y, et autres
Publié: (2016)

Effects of age, sex, and ethnicity on bone health status of the elderly in Kuala Lumpur, Malaysia
par: Chin KY, et autres
Publié: (2016)

Osteoporosis screening and risk management
par: Consuelo H Wilkins
Publié: (2007)

Clinical challenges in the management of osteoporosis
par: Sheryl F Vondracek, et autres
Publié: (2008)

Prevalence and Risk Factors of Osteoporosis in Chinese Postmenopausal Women Awaiting Total Knee Arthroplasty
par: Tao Y, et autres
Publié: (2021)

Osteoporosis in the aging male: Treatment options
par: Stephen P Tuck, et autres
Publié: (2008)

Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial
par: Jiang Y, et autres
Publié: (2014)

The Role of Sphingolipid Metabolism in Bone Remodeling
par: Tang Qi, et autres
Publié: (2021)

Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool
par: Lin JS, et autres
Publié: (2016)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
par: Raja Bobba, et autres
Publié: (2007)